Atherosclerosis as an inflammatory disease: implications for therapy

Area of Science:

• Cardiovascular Science
• Pathophysiology
• Molecular Biology

Background:

• Cardiovascular disease is a primary cause of mortality in the US.
• Atherosclerosis encompasses diverse pathological lesions with varying clinical outcomes.
• Current treatments include pharmacologic therapy, lifestyle changes, and interventions.

Purpose of the Study:

• To review the current understanding of atherosclerosis pathophysiology.
• To define atherosclerosis as a multifactorial process.
• To explore potential therapeutic targets for atherosclerosis control.

Main Methods:

• Literature review of pathophysiological mechanisms.
• Analysis of molecular and cellular interactions in atherosclerosis development.
• Identification of inflammatory process sites for therapeutic intervention.

Main Results:

• Atherosclerosis involves complex interactions: lipid metabolism, monocyte activation, endothelial cells, and cytokines.
• It is a multifactorial process with intricate molecular and cellular pathways.
• Therapeutic control may be achieved by targeting specific sites within the inflammatory process.

Conclusions:

• Understanding atherosclerosis pathophysiology is crucial for developing effective treatments.
• Targeting inflammatory pathways, growth factors, transcription factors, and genes presents viable therapeutic strategies.
• Interventions aimed at specific molecular and cellular mechanisms can potentially control atherosclerosis.